EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Seelos Therapeutics's enterprise value is $16.24 Mil.
Seelos Therapeutics's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was $0.00 Mil. Therefore, Seelos Therapeutics's EV-to-Revenue for today is .
The historical rank and industry rank for Seelos Therapeutics's EV-to-Revenue or its related term are showing as below:
During the past 13 years, the highest EV-to-Revenue of Seelos Therapeutics was 95.78. The lowest was 0.67. And the median was 1.41.
SEEL's EV-to-Revenue is not ranked *
in the Biotechnology industry.
Industry Median: 8.21 * Ranked among companies with meaningful EV-to-Revenue only.
The historical data trend for Seelos Therapeutics's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Seelos Therapeutics's EV-to-Revenue
For the Biotechnology subindustry, Seelos Therapeutics's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Seelos Therapeutics's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Seelos Therapeutics's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Seelos Therapeutics's EV-to-Revenue falls into.
Seelos Therapeutics's current Enterprise Value is $16.24 Mil.
Seelos Therapeutics's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Seelos Therapeutics's share price for today is $1.63.
Seelos Therapeutics's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Seelos Therapeutics EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Seelos Therapeutics's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Seelos Therapeutics (Seelos Therapeutics) Business Description
Seelos Therapeutics Inc is a clinical-stage biotechnology company. The company is focused on developing products that address unmet needs in Central Nervous System (CNS) disorders and other rare disorders.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SEEL has been successfully added to your 